NOVEL USE OF MAYDIS STIGMA EXTRACT IN PROPHYLAXIS AND THERAPY OF SLEEP DISORDER - KONKUK UNIV GLOCAL IND ACADEMIC COLLABORATION FOUND

Title:

NOVEL USE OF MAYDIS STIGMA EXTRACT IN PROPHYLAXIS AND THERAPY OF SLEEP DISORDER

Document Type and Number:

WIPO Patent Application WO/2019/172668

Kind Code:

A1

Abstract:

The present invention provides a novel use of a Maydis stigma extract in prophylaxis, alleviation, or therapy of sleep disorder. A Maydis stigma extract has the effect of reducing sleep onset latency and increasing sleep duration, as high as or higher than the effect of ketamine or pentobarbital, which are conventionally used as soporifics. As a natural substance, the Maydis stigma extract does not cause side effects, such as cytotoxicity, resistance, or dependency, even when used for a long term.

Inventors:

SHIN CHAN YOUNG (KR)
HAN SEOL HEUI (KR)
KWON KYOUNG JA (KR)
KIM RYOUNG EUN (KR)
JOO SO HYUN (KR)

Application Number:

PCT/KR2019/002640

Publication Date:

September 12, 2019

Filing Date:

March 07, 2019

Export Citation:

Click for automatic bibliography generation Help

Assignee:

KONKUK UNIV GLOCAL IND ACADEMIC COLLABORATION FOUND (KR)
NEUROVENTI (KR)

International Classes:

A61K36/899; A23L33/105; A61P25/20

Foreign References:

CN105795292A	2016-07-27
KR20070092025A	2007-09-12
CN105104979A	2015-12-02
CN107496755A	2017-12-22
KR20010074322A	2001-08-04

Attorney, Agent or Firm:

ERUUM & LEEON INTELLECTUAL PROPERTY LAW FIRM (KR)

Download PDF:

View/Download PDF PDF Help

Previous Patent: SLEEPING ENVIRONMENT CONTROL DEVICE USING REINFORCEMENT LEARNING

Next Patent: METHOD AND DEVICE FOR TRANSMITTING DATA IN CASE OF PDCP VERSION CHANGE IN WIRELESS COMMUNICATION SYS...